Diagnostic 25 hydroxyvitamin D (25-OH-(VD3+VD2)) antibodies (anti-25 hydroxyvitamin D, anti-25-OH-(VD3+VD2)) and diagnostic recombinant25 hydroxyvitamin D (25-OH-(VD3+VD2)) ) antigens (recombinant25 hydroxyvitamin D (25-OH-(VD3+VD2)) protein) forBone metabolism 25-OH-(VD3+VD2) detection in ELISA test,Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Product Details
Vitamin D is a nutrient that is essential for healthy bones and teeth. There are two forms of vitamin D that are important for nutrition: vitamin D2 and vitamin D3. Vitamin D2 mainly comes from fortified foods like breakfast cereals, milk, and other dairy items. Vitamin D3 is made by your own body when you are exposed to sunlight. It is also found in some foods, including eggs and fatty fish, such as salmon, tuna, and mackerel.
In your bloodstream, vitamin D2 and vitamin D3 are changed into a form of vitamin D called 25 hydroxyvitamin D, also known as 25(OH)D. A vitamin D blood test measures the level of 25(OH)D in your blood. Abnormal levels of vitamin D can indicate bone disorders, nutrition problems, organ damage, or other medical conditions.
A vitamin D test is used to screen for or monitor bone disorders. It is also sometimes used to check vitamin D levels in people with chronic illnesses such as asthma, psoriasis, and certain autoimmune diseases.” “Genemedi produces core diagnostic ingredients for test of diagnostic,diagnostics,diagnostic antibody,diagnostic antigen,diagnostics antibody,diagnostics antigen,antibody,antigen,ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT, and related syndrome.
GeneMedi offers paired diagnostics grade 25 hydroxyvitamin D) antibodies (monoclonal antibody, mab) and 25 hydroxyvitamin D) antigens for diagnostic,diagnostics,diagnostic antibody,diagnostic antigen,diagnostics antibody,diagnostics antigen,antibody,antigen,ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT, rapid test kit of 25 hydroxyvitamin D) testing in ELISA test,Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
All the antibodies and antigens for diagnostic,diagnostics,diagnostic antibody,diagnostic antigen,diagnostics antibody,diagnostics antigen,antibody,antigen,ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT, test are suitable for in functional ELISA, and other immunoassays in dignostics.The antibodies can act as a capture antibody and detection antibody.The antigens can be used for antibodies rapid test of diagnostic,diagnostics,diagnostic antibody,diagnostic antigen,diagnostics antibody,diagnostics antigen,antibody,antigen,ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT,.”
Product Description
|
Cat No.
|
GMP-25-OH-VD3-VD2
|
|
Product Name
|
BSA-25 hydroxyvitamin D (25-OH-(VD3+VD2)) / OVA-25 hydroxyvitamin D (25-OH-(VD3+VD2))
|
|
Expression platform
|
Synthetic
|
|
Bioactivity validation
|
25 hydroxyvitamin D (25-OH-(VD3+VD2)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in 25-OH-(VD3+VD2) level test of Metabolic diseases (bone fracture, coronary heart disease,
cancer, and all-cause mortality) and related syndrome evaluation
|
|
Products description
|
Competitive immunoassay-validated hapten-carrier conjugates BSA-25 hydroxyvitamin D (25-OH-(VD3+VD2)) / OVA-25 hydroxyvitamin D (25-OH-(VD3+VD2)) is Synthetic.
|
|
Purity
|
|
|
Application
|
Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
|
|
Formulation
|
Lyophilized from sterile PBS, PH 7.4
|
|
Storage
|
Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.
|
|
Cat No.
|
GMP-25-OH-VD3-VD2
|
|
Product Name
|
Anti-human 25 hydroxyvitamin D (25-OH-(VD3+VD2)) mouse monoclonal antibody (mAb)
|
|
Expression platform
|
Hybridoma
|
|
Isotypes
|
Mouse IgG
|
|
Bioactivity validation
|
25 hydroxyvitamin D (25-OH-(VD3+VD2)) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other 25 hydroxyvitamin D (25-OH-(VD3+VD2)) antibodies in 25-OH-(VD3+VD2) level test of Metabolic diseases (bone fracture, coronary heart disease,
cancer, and all-cause mortality) and related syndrome evaluation.
|
|
Tag
|
mFc
|
|
Products description
|
Anti-human 25 hydroxyvitamin D (25-OH-(VD3+VD2)) mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by hybridoma technology.
|
|
Specics
|
mouse
|
|
Purity
|
Purity: ≥95% （SDS-PAGE）
|
|
Application
|
Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
|
|
Formulation
|
Lyophilized from sterile PBS, PH 7.4
|
|
Storage
|
Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.
|
Diagnostic antibodies and antigens for Epilepsy-related valproate (VPA) toxicity testing: Sodium valproate (VPA)
Valproate is a commonly used antiepileptic drug for the treatment of epilepsy and seizures. It is safe for use in both adults and children more than three years of age. Valproate toxicity can occur both accidentally and intentionally. Acute valproate overdose usually presents with CNS depression/encephalopathy, electrolyte abnormalities such as hypernatremia, elevated transaminase levels, hyperammonemia, and hepatoxicity. In patients with a severe overdose of valproate, patients can present with hypotension, tachycardia, respiratory depression, metabolic acidosis, cerebral edema, and valproate-related hyperammonemic encephalopathy which may progress to coma and death. GENEMEDI developed the Gastrin-17 (G-17) antigens and antibodies for the diagnosis of valproate toxicity based on ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
